tiprankstipranks
The Fly

IGM Biosciences CEO Fred Schwarzer, CSO Bruce Keyt, CMO Chris Takimoto step down

IGM Biosciences CEO Fred Schwarzer, CSO Bruce Keyt, CMO Chris Takimoto step down

As part of the company’s strategic pivot to autoimmunity, Fred Schwarzer, CEO, president and director, and Bruce Keyt, chief scientific officer, or CSO, will step down from their current roles at the company. Schwarzer and Keyt are expected to remain as consultants. Chris Takimoto, chief medical officer, is stepping down from his current role to pursue an opportunity outside the company.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Questions or Comments about the article? Write to editor@tipranks.com